Broadview Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
75
- Portfolio
-
30
- Exits
-
20
Broadview Ventures General Information
Description
Founded in 2008, Broadview Ventures is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in companies operating in the small molecules, biologics, generic medicines, cell, gene therapies, implantable, interventional, remote monitoring devices, stand-alone or companion diagnostics, including in vitro, imaging, and digital technologies sectors based in North America, Europe, and Israel. The firm's primary investment goal is to improve human health in the areas of cardiovascular disease and stroke.
Contact Information
Website
www.broadviewventures.org
Year Founded
2008
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Impact Investing
Primary Office
- 265 Franklin Street
- Suite 1902
- Boston, MA 02110
- United States
+1 (617) 000-0000
Broadview Ventures Investments & Acquisitions (75)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cardiosense | 08-Dec-2022 | Early Stage VC | 000.00 | Monitoring Equipment | Startup | 000000 00000000 |
| 0000 0000000 | 23-Nov-2022 | 00000 00000 | 0000 | Surgical Devices | Pre-Clinical Trials | |
| 0000000000 (000000 | 31-Aug-2022 | 00000 00000 | 000.00 | Therapeutic Devices | Startup | |
| 000 0000000 | 29-Apr-2022 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | |
| 0000 000000000000 | 09-Feb-2022 | 0000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000000 00000000 |
| 000000000 | 04-Feb-2022 | 00000 00000 | 00.00 | Surgical Devices | Generating Revenue | |
| 000000 0000000 000 | 24-Jan-2022 | 0000 00000 | Therapeutic Devices | Clinical Trials - Phase 1 | 00000000000 00000000 | |
| 000000000 | 30-Dec-2021 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | |
| Kantum Pharma | 12-Jul-2021 | Seed Round | 00.000 | Biotechnology | Generating Revenue | 000000 0000000 00. |
| Comanche Biopharma | 28-Jun-2021 | Early Stage VC | 0000 | Biotechnology | Generating Revenue |
Broadview Ventures Exits (20)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cardialen | 14-Dec-2022 | Merger/Acquisition | |
| 0000000000 | 01-May-2022 | 000 00 00000000 | |
| 000000000 | 02-Sep-2021 | 0000000 000000 | 000.00 |
| 0000000000 0000000 | 08-May-2020 | 000 00 00000000 | |
| 0000 000000000000 | 01-May-2020 | 000 | 0000 |
| 000000 000000000 | 01-May-2020 | 000 00 00000000 | |
| 000000000 0000000 | 01-Jan-2020 | 0000000000: 000000 | |
| 000000000 00000000 | 27-Dec-2017 | 000 00 00000000 | |
| Apama Medical | 10-Oct-2017 | Merger/Acquisition | 00000 |
| Remedy Pharmaceuticals | 01-May-2017 | Secondary Transaction - Private |
Broadview Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Broadview Ventures Team (30)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Christopher Colecchi | Managing Director | 0 | 0 | Boston, MA | |
| Benjamin Kreitman | Principal | 0 | 0 | Boston, MA | |
| Hewmun Lau | Principal | 0 | Boston, MA | ||
| Maria Berkman MD | Director & Head of the MedTech Practice | 00 | 0 | Boston, MA | |
| Christopher De Souza Ph.D | Director | 0 | 0 | Boston, MA |
Broadview Ventures Co-Investors (79)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Hatteras Venture Partners | 3 | 0 |
|
|
|
| Long View Equity Partners | 0 | 0 | 0 |
|
|
| Catalyst Health Ventures | 0 | 0 |
|
|
|
| Epidarex Capital | 0 |
|
|
||
| Vensana Capital | 0 | 0 |
|
|